Sjögren's SyndromeReferencesCitationsArthritis Society (2006). Sjögren's syndrome. Available online: http://www.arthritis.ca/types%20of%20arthritis/sjogrens%20syndrome/default.asp?s=1. Jonsson R, et al. (2005). Sjögren's syndrome. In WJ
Koopman, LW Moreland, eds., Arthritis and Allied Conditions: A
Textbook of Rheumatology, 15th ed., vol. 2, pp. 1681–1705. Philadelphia:
Lippincott Williams and Wilkins. Fox RI (2000). Sjögren's syndrome: Current therapies
remain inadequate for a common disease. Expert Opinion on
Investigational Drugs, 9(9): 2007–2016. Fox RI, et al. (2000). Update in Sjögren
syndrome. Current Opinion in Rheumatology, 12(5):
391–398. Petrone D, et al. (2002). A double-blind, randomized,
placebo-controlled study of cevimeline in Sjögren's syndrome patients with
xerostomia and keratoconjunctivitis sicca. Arthritis and
Rheumatism, 46(3): 748–754. Fife RS, et al. (2002). Cevimeline for the treatment
of xerostomia in patients with Sjögren's syndrome. Archives of
Internal Medicine, 162: 1293–1300. Carsons S (2005). Sjögren's syndrome. In ED Harris Jr
et al., eds., Kelley's Textbook of Rheumatology, 7th
ed., vol. 2, chap. 69, pp. 1105–1124. Philadelphia: Elsevier
Saunders. Steinfeld SD, et al. (2002). Infliximab in primary
Sjögren's syndrome. Arthritis and Rheumatism, 46(12):
3301–3303.
Go to previous section | Go to top of page | Go to next section |
| | Author: | Carrie Henley Jan Nissl, RN, BS | Last Updated: July 27, 2006 | | Medical Review: | Adam Husney, MD - Family Medicine Tom Bailey, MD - Family Medicine Stanford M. Shoor, MD - Rheumatology | © 1995-2008 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.
| 
| |
| |